Sinclair Research poaches Covance, Lilly veteran Wakefield

(Image: AstraZeneca)

Preclinical contract research organization Sinclair Research has carved out a new role for G. Alex Wakefield as he becomes its vice president of research and operations.

Here, the former Covance and Eli Lilly executive will have overall responsibility for the company’s research services and its operational processes, while also being charged with “driving the growth of Sinclair’s business model and fostering positive relationships with new and current customers,” according a company statement.

Sinclair offers animal efficacy models, IND-enabling toxicology services and research capabilities to biopharma, animal health and medical device companies.

“Alex’s combination of experience across pharma and CRO services coupled with his scientific knowledge of both efficacy and safety animal modeling will enable Sinclair to move to the next level in size, scope and market leadership,” said Guy Bouchard, Sinclair president.

“2017 was an outstanding year for Sinclair Research, particularly related to GLP services and regulatory compliance. As a seasoned industry executive, Alex’s proven leadership skills will be invaluable as we continue to grow our business.”